Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Goldman Sachs reveals its top non-AI stocks
11:08pm, Tuesday, 26'th May 2026
The artificial intelligence (AI) boom continues to set the direction for global financial markets in 2026, but Goldman Sachs strategists argue that opportunities exist outside this tech narrative as w
Is Eli Lilly Stock an Undervalued Stock to Buy?
06:17pm, Tuesday, 26'th May 2026
The pharma company is booming due to innovative treatments.
Lilly Targets Vaccines With $3.8 Billion Acquisition Push
01:17pm, Tuesday, 26'th May 2026
Eli Lilly (LLY) is stepping back into infectious diseases with a three-deal vaccine push worth as much as $3.8 billion, giving investors another signal that the
Eli Lilly targets vaccines market with $3.8B acquisition of three biotech firms
12:04pm, Tuesday, 26'th May 2026
Eli Lilly and Co (NYSE:LLY) has announced agreements to acquire three vaccine developers, Curevo, LimmaTech Biologics AG, and Vaccine Company, in transactions valued at up to $3.83 billion combined, a
Lilly Gets Back Into the Vaccine Business With New Deals
10:44am, Tuesday, 26'th May 2026
Eli Lilly & Co. is buying three clinical-stage vaccine developers for as much as $3.8 billion as it looks to become a leader in infectious diseases. The drugmaker has been using cash from its obesity
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 26'th May 2026
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
4 Large-Cap Pharma Stocks to Buy as Industry Recovery Accelerates
09:51am, Tuesday, 26'th May 2026
In the Large-Cap Pharmaceuticals industry, LLY, J&J, NVO and BAYRY are worth retaining as the industry shows some recovery.
Eli Lilly Goes On A $3.83 Billion Acquisition Spree. Where's It Pushing Now?
09:22am, Tuesday, 26'th May 2026
Eli Lilly acquired three infectious diseases companies for up to $3.83 billion. Lilly stock ticked higher in response.
If Viking Therapeutics Is Acquired, Here’s Who Wins
08:50am, Tuesday, 26'th May 2026
Polymarket traders are watching one biotech more closely than any other for an acquisition. Viking Therapeutics (NASDAQ: VKTX) carries a 38.5% implied probability of being acquired before 2027, with a
Eli Lilly targets vaccines market with $3.8B acquisition of three biotech firms
08:03am, Tuesday, 26'th May 2026
Eli Lilly and Co (NYSE:LLY) has announced agreements to acquire three vaccine developers, Curevo, LimmaTech Biologics AG, and Vaccine Company, in...
Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals
07:50am, Tuesday, 26'th May 2026
The deals are part of Eli Lilly's effort to expand into infectious disease research and development. Shares edged higher in premarket trading on the news.
First Look: Oil Slides on Iran Talks; Lilly M&A Ferrari's EV Debut
07:40am, Tuesday, 26'th May 2026
Stock News Oil drops on Iran peace signals: Crude fell 6â7% as President Trump said talks to reopen the Strait of Hormuz are âproceeding nicely,â while JP
Lilly announces three acquisitions to build infectious disease portfolio
06:45am, Tuesday, 26'th May 2026
Agreements with Curevo, LimmaTech Biologics and Vaccine Company address viral pathogens linked to long-term neurological and oncological risk, and bacterial pathogens that are difficult to prevent or
Lilly Agrees to Buys Trio of Vaccine Developers
06:35am, Tuesday, 26'th May 2026
The weight-loss drug market leader is renewing a focus on infectious-disease prevention.
Eli Lilly weight loss drug data supports long-term obesity market position, says UBS
02:48pm, Monday, 25'th May 2026
Eli Lilly and Co (NYSE:LLY) last week reported late-stage weight loss data for retatrutide, which UBS analysts highlighted showed “solid strong weight loss efficacy” and were broadly in line with
